SK Capital, a NYC-based private investment firm, closed its Fund VI, at $2.95 Billion.
Founded in 2007, the firm has focused exclusively on investments in the specialty materials, ingredients, and life sciences industries. With operating and investing experience in these sectors, the team of more than 70 professionals works closely with management teams to expand portfolio companies with improved strategic positioning, growth, and profitability, as well as lower operating risk. Its portfolio of businesses generates revenues of approximately $14 Billion annually, employs more than 25,000 people globally, and operates more than 200 plants in over 30 countries.
The firm currently has approximately $9 Billion in assets under management.
FinSMEs
04/04/2024